Locations
Watertown, MA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Other
founded in
2022
En Plus One Biosciences is a biotechnology company focused on harnessing the power of enzymes to develop innovative RNA synthesis technologies. Their proprietary ez RNA™ platform aims to deliver high-quality RNA oligonucleotides at scale, addressing the growing demand for RNA therapeutics. The company differentiates itself through its advanced enzymatic synthesis methods, which are designed to be more efficient and cost-effective compared to traditional approaches. With a strong foundation in scientific expertise and collaborations, En Plus One is positioned to make significant contributions to the RNA therapeutics market, particularly in the development of treatments for various diseases.
Something looks off?